For analysing the genetic material present in cells and tissues, molecular biology reagents are frequently used. These tests could involve gene expression, biochemical analysis, protein production, DNA and RNA analysis, and many more techniques for detecting genetic alterations. Diagnostic testing, drug discovery, and life science research are just a few of the many industries that utilize molecular biology enzymes, kits, and reagents. These products are used to examine cell surface indicators in the human body that are recognized to serve as therapeutic and diagnostic targets. One of the most frequently used preparative and diagnostic techniques in molecular biology is the polymerase chain reaction, which includes reverse transcriptase-polymerase chain reactions. Different enzymes, kits, and reagents are also needed for this procedure, which can also be used to diagnose genetic diseases and create DNA fingerprints.
The primary element fuelling the market's expansion is the increased burden of infectious diseases and genetic disorders. For instance, a survey by the World Health Organization found that 12,368 people tested positive for influenza between January 24 and February 6, 2022, with 8,423 (68.1%) having influenza A and 3,945 (31.9%), having influenza B. 171 (6.4%) influenza A (H1N1) pdm09 viruses and 2,483 (93.6%) influenza A viruses were subtypes of influenza A viruses (H3N2). As a result, the market may be driven by the need for more technologically advanced products given the rising occurrence of various influenza kinds worldwide.
Increased research and development efforts related to molecular biology enzyme applications in the biotechnology industry are a prominent factor driving the expansion in the market for molecular biology enzymes, kits, and reagents.
Gene mapping and gene sequencing also make use of a variety of molecular biology enzyme kits and reagents. As a result, the market for molecular biology enzymes, kits, and reagents is growing as the number of genome projects increases globally.
The Global molecular biology reagents and enzyme market was estimated to be $15.3 billion in 2021. Due to driving forces like the increasing burden of infectious diseases and genetic disorders, and increased R&D efforts on molecular biology enzymes, gene mapping, and gene sequencing this market is expected to reach $50.5 billion by 2030 at a CAGR of 14.3% in the forecast period of 2022-2030.
Market players in Molecular Biology Reagents Market are Thermo Fisher Scientific, Inc., LGC Limited, Merck KGaA, Promega Corporation, New England Biolabs, Illumina, Inc., Takara Bio Inc., Qiagen, FUJIFILM Wako Pure Chemical Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Sigma-Aldrich Co., Bio-Rad Laboratories, Inc., Bio Basic Inc., Jena Bioscience GmbH, BD, Abbott, Beckman Coulter, Inc., Life Technologies and MBR, Inc.
According to application segmentation, the market is segmented into polymerase chain reaction (PCR), Sequencing, Cloning, epigenetics, Restriction digestion, and synthetic biology. The largest market share of 28.3% was accounted for Polymerase chain reaction in 2020, because of the low cost of PCR equipment, the majority of end users use PCR equipment, and the extensive use of PCR for molecular diagnostic assays in hospitals and clinics.
Based on end users global market is segmented into, academic and research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnological companies, and others. The pharmaceutical & biotechnological segment had the highest market share of 35% in 2021.
Due to the rising prevalence of chronic diseases like cancer, cardiovascular disease, rare diseases, genetic disorders, and infectious diseases, rising healthcare spending, rising demand for personalized medicines, and technological advancement in the region, North America is predicted to account for a sizeable portion of the global market for molecular biology enzymes, kits, and reagents.
The market is anticipated to grow faster than average due to the increase in infectious diseases, genetic disorders, and chronic diseases. For instance, the American Cancer Society's 2022 estimates project that there will be 34,500 fatalities and 268,490 new cases of prostate cancer in the United States in 2022. Moreover, 1,414,259 persons received prostate cancer diagnoses in 2020, according to the same source. Meanwhile, 151,030 persons in the United States are expected to receive a colorectal cancer diagnosis in May 2022, according to information provided by the American Society of Clinical Oncology. Also, according to the same source, colorectal cancer will be diagnosed in 1,880,725 additional persons in 2020.
Molecular Biology Reagents are mostly used for analysing the genetic material present in cells and tissues. Gene expression, biochemical analysis, protein production, and DNA and RNA analysis are tests that are involved in this analysis. All these analyses getting pace as the infectious diseases and genetic disorders are increasing day by day. To cater to all these diseases and disorders intensive research work like research and development efforts related to the molecular biological enzyme, Gene mapping, and gene sequencing is required. The molecular Biology Reagents and Enzyme market is expected to reach $50.5 billion by 2030. Based on application market is segmented into polymerase chain reaction (PCR), Sequencing, Cloning, epigenetics, Restriction digestion, and synthetic biology. Based on end users global market is segmented into, academic and research institutes, hospitals & diagnostic centers, and pharmaceutical & biotechnological. And based on the product market segmented into Kits & reagents, and Enzymes. North America is predicted to account for a sizeable portion of the global market for molecular biology enzymes, kits, and reagents.